Skip to main content
Top
Published in: Cancer Causes & Control 1/2012

01-01-2012 | Original paper

Pathways to the diagnosis of thyroid cancer in New South Wales: a population-based cross-sectional study

Authors: Clare Kahn, Leonardo Simonella, Mark Sywak, Steven Boyages, Owen Ung, Dianne O’Connell

Published in: Cancer Causes & Control | Issue 1/2012

Login to get access

Abstract

Background

Over the past few decades, an increase in the incidence of thyroid cancer has been recorded in many countries around the world including Australia. Heightened medical surveillance and increased technological sensitivity could be contributing to greater detection of asymptomatic disease.

Objectives

To describe the pathways to diagnosis of thyroid cancer for a cohort of newly diagnosed patients in New South Wales (NSW), Australia, and compare these pathways by age, sex, place of residence, ethnic background, medical insurance status, and disease characteristics.

Methods

A total of 452 newly diagnosed cases of thyroid cancer were recruited through the population-based NSW Central Cancer Registry. Participants completed a questionnaire and diary of doctor visits and investigations that led to their diagnosis. Tumor characteristics were obtained from pathology reports.

Results

Forty percent of patients initially presented to their doctor with a lump or symptom specific to thyroid cancer and 60% had their cancer detected incidentally during a medical encounter. Men were more likely than women to be diagnosed after imaging for another health concern versus reporting a thyroid lump or symptom (p = 0.001). Thyroid cancer diagnosis after imaging for another health concern increased with age (p = 0.023), and larger tumors were less likely to be diagnosed after treatment for a benign thyroid disease (p = 0.040).

Conclusion

As the majority of participants had incidental diagnoses, the reported incidence of thyroid cancer is likely to be influenced by diagnostic technology and medical surveillance practices. This, however, probably only partly explains the observed rise in the incidence of thyroid cancer in NSW.
Literature
1.
go back to reference Burgess JR (2002) Temporal trends for thyroid carcinoma in Australia: an increasing incidence of papillary thyroid carcinoma (1982–1997). Thyroid 12(2):141–149PubMedCrossRef Burgess JR (2002) Temporal trends for thyroid carcinoma in Australia: an increasing incidence of papillary thyroid carcinoma (1982–1997). Thyroid 12(2):141–149PubMedCrossRef
2.
go back to reference Chen AY, Jemal A, Ward EM (2009) Increasing incidence of differentiated thyroid cancer in the United States, 1988–2005. Cancer 115(16):3801–3807PubMedCrossRef Chen AY, Jemal A, Ward EM (2009) Increasing incidence of differentiated thyroid cancer in the United States, 1988–2005. Cancer 115(16):3801–3807PubMedCrossRef
3.
go back to reference Colonna M, Grosclaude P, Remontet L et al (2002) Incidence of thyroid cancer in adults recorded by French cancer registries (1978–1997). Eur J Cancer 38(13):1762–1768PubMedCrossRef Colonna M, Grosclaude P, Remontet L et al (2002) Incidence of thyroid cancer in adults recorded by French cancer registries (1978–1997). Eur J Cancer 38(13):1762–1768PubMedCrossRef
4.
go back to reference Davies L, Welch HG (2006) Increasing incidence of thyroid cancer in the United States, 1973–2002. JAMA 295(18):2164–2167PubMedCrossRef Davies L, Welch HG (2006) Increasing incidence of thyroid cancer in the United States, 1973–2002. JAMA 295(18):2164–2167PubMedCrossRef
5.
go back to reference Kilfoy BA, Zheng T, Holford TR et al (2009) International patterns and trends in thyroid cancer incidence, 1973–2002. Cancer Causes Control 20(5):525–531PubMedCrossRef Kilfoy BA, Zheng T, Holford TR et al (2009) International patterns and trends in thyroid cancer incidence, 1973–2002. Cancer Causes Control 20(5):525–531PubMedCrossRef
6.
go back to reference Colonna M, Guizard AV, Schvartz C et al (2007) A time trend analysis of papillary and follicular cancers as a function of tumour size: a study of data from six cancer registries in France (1983–2000). Eur J Cancer 43(5):891–900PubMedCrossRef Colonna M, Guizard AV, Schvartz C et al (2007) A time trend analysis of papillary and follicular cancers as a function of tumour size: a study of data from six cancer registries in France (1983–2000). Eur J Cancer 43(5):891–900PubMedCrossRef
7.
go back to reference Leenhardt L, Grosclaude P, Cherie-Challine L (2004) Increased incidence of thyroid carcinoma in France: a true epidemic or thyroid nodule management effects? Report from the French Thyroid Cancer Committee. Thyroid 14(12):1056–1060PubMedCrossRef Leenhardt L, Grosclaude P, Cherie-Challine L (2004) Increased incidence of thyroid carcinoma in France: a true epidemic or thyroid nodule management effects? Report from the French Thyroid Cancer Committee. Thyroid 14(12):1056–1060PubMedCrossRef
8.
go back to reference Verkooijen HM, Fioretta G, Pache J-C et al (2003) Diagnostic changes as a reason for the increase in papillary thyroid cancer incidence in Geneva, Switzerland. Cancer Causes Control 14(1):13–17PubMedCrossRef Verkooijen HM, Fioretta G, Pache J-C et al (2003) Diagnostic changes as a reason for the increase in papillary thyroid cancer incidence in Geneva, Switzerland. Cancer Causes Control 14(1):13–17PubMedCrossRef
9.
go back to reference Kovacs GL, Gonda G, Vadasz G et al (2005) Epidemiology of thyroid microcarcinoma found in autopsy series conducted in areas of different iodine intake. Thyroid 15(2):152–157PubMedCrossRef Kovacs GL, Gonda G, Vadasz G et al (2005) Epidemiology of thyroid microcarcinoma found in autopsy series conducted in areas of different iodine intake. Thyroid 15(2):152–157PubMedCrossRef
11.
go back to reference Kent WDT, Hall SF, Isotalo PA, Houlden RL, George RL, Groome PA (2007) Increased incidence of differentiated thyroid carcinoma and detection of subclinical disease. CMAJ 177(11):1357–1361PubMedCrossRef Kent WDT, Hall SF, Isotalo PA, Houlden RL, George RL, Groome PA (2007) Increased incidence of differentiated thyroid carcinoma and detection of subclinical disease. CMAJ 177(11):1357–1361PubMedCrossRef
12.
go back to reference Scheiden R, Keipes M, Bock C, Dippel W, Kieffer N, Capesius C (2006) Thyroid cancer in Luxembourg: a national population-based data report (1983–1999). BMC Cancer 6:102PubMedCrossRef Scheiden R, Keipes M, Bock C, Dippel W, Kieffer N, Capesius C (2006) Thyroid cancer in Luxembourg: a national population-based data report (1983–1999). BMC Cancer 6:102PubMedCrossRef
13.
go back to reference Yu GP, Li JC, Branovan D, McCormick S, Schantz SP (2010) Thyroid cancer incidence and survival in the National Cancer Institute Surveillance, Epidemiology, and End Results race/ethnicity groups. Thyroid 20:465–473PubMedCrossRef Yu GP, Li JC, Branovan D, McCormick S, Schantz SP (2010) Thyroid cancer incidence and survival in the National Cancer Institute Surveillance, Epidemiology, and End Results race/ethnicity groups. Thyroid 20:465–473PubMedCrossRef
14.
go back to reference Zhu C, Zheng T, Kilfoy BA et al (2009) A birth cohort analysis of the incidence of papillary thyroid cancer in the United States, 1973–2004. Thyroid 19(10):1061–1066PubMedCrossRef Zhu C, Zheng T, Kilfoy BA et al (2009) A birth cohort analysis of the incidence of papillary thyroid cancer in the United States, 1973–2004. Thyroid 19(10):1061–1066PubMedCrossRef
15.
go back to reference Ward EM, Jemal A, Chen A (2010) Increasing incidence of thyroid cancer: is diagnostic scrutiny the sole explanation? Fut Oncol 6:185–188CrossRef Ward EM, Jemal A, Chen A (2010) Increasing incidence of thyroid cancer: is diagnostic scrutiny the sole explanation? Fut Oncol 6:185–188CrossRef
16.
go back to reference Enewold L, Zhu K, Ron E et al (2009) Rising thyroid cancer incidence in the United States by demographic and tumor characteristics, 1980–2005. Cancer Epidemiol Biomarkers Prev 18(3):784–791PubMedCrossRef Enewold L, Zhu K, Ron E et al (2009) Rising thyroid cancer incidence in the United States by demographic and tumor characteristics, 1980–2005. Cancer Epidemiol Biomarkers Prev 18(3):784–791PubMedCrossRef
17.
go back to reference Preston-Martin S, Franceschi S, Ron E, Negri E (2003) Thyroid cancer pooled analysis from 14 case–control studies: what have we learned? Cancer Causes Control 14:787–789PubMedCrossRef Preston-Martin S, Franceschi S, Ron E, Negri E (2003) Thyroid cancer pooled analysis from 14 case–control studies: what have we learned? Cancer Causes Control 14:787–789PubMedCrossRef
18.
go back to reference Zivaljevic V, Vlajinac H, Jankovic R et al (2003) Case–control study of female thyroid cancer—menstrual, reproductive and hormonal factors. Eur J Cancer Prev 12:63–66PubMedCrossRef Zivaljevic V, Vlajinac H, Jankovic R et al (2003) Case–control study of female thyroid cancer—menstrual, reproductive and hormonal factors. Eur J Cancer Prev 12:63–66PubMedCrossRef
19.
go back to reference Dal ML, Bosetti C, La VC, Franceschi S (2009) Risk factors for thyroid cancer: an epidemiological review focused on nutritional factors. Cancer Causes Control 20:75–86CrossRef Dal ML, Bosetti C, La VC, Franceschi S (2009) Risk factors for thyroid cancer: an epidemiological review focused on nutritional factors. Cancer Causes Control 20:75–86CrossRef
20.
go back to reference Stavrou E, Baker D, McElroy H, Bishop J (2008) Thyroid cancer in New South Wales. Cancer Institute NSW, Sydney Stavrou E, Baker D, McElroy H, Bishop J (2008) Thyroid cancer in New South Wales. Cancer Institute NSW, Sydney
21.
go back to reference Tracey EA, Supramaniam R, Chen W (2003) Cancer in New South Wales: incidence and mortality 2001. The Cancer Council NSW, Sydney Tracey EA, Supramaniam R, Chen W (2003) Cancer in New South Wales: incidence and mortality 2001. The Cancer Council NSW, Sydney
22.
go back to reference Smith DP, Supramaniam R, King MT, Ward J, Berry M, Armstrong BK (2007) Age, health, and education determine supportive care needs of men younger than 70 years with prostate cancer. J Clin Oncol 20:2560–2566CrossRef Smith DP, Supramaniam R, King MT, Ward J, Berry M, Armstrong BK (2007) Age, health, and education determine supportive care needs of men younger than 70 years with prostate cancer. J Clin Oncol 20:2560–2566CrossRef
23.
go back to reference Royston P, Ambler G, Sauerbrei W (1999) The use of fractional polynomials to model continuous risk variables in epidemiology. Int J Epidemiol 28:964–974PubMedCrossRef Royston P, Ambler G, Sauerbrei W (1999) The use of fractional polynomials to model continuous risk variables in epidemiology. Int J Epidemiol 28:964–974PubMedCrossRef
24.
go back to reference New South Wales Central Cancer Registry (1986) Cancer in New South Wales: incidence and mortality 1980. Department of Health NSW, Sydney New South Wales Central Cancer Registry (1986) Cancer in New South Wales: incidence and mortality 1980. Department of Health NSW, Sydney
25.
go back to reference Tracey E, Alam N, Chen W, Bishop J (2008) Cancer in New South Wales: incidence and mortality 2006. Cancer Institute NSW, Sydney Tracey E, Alam N, Chen W, Bishop J (2008) Cancer in New South Wales: incidence and mortality 2006. Cancer Institute NSW, Sydney
26.
go back to reference Burgess JR, Tucker P (2006) Incidence trends for papillary thyroid carcinoma and their correlation with thyroid surgery and thyroid fine-needle aspirate cytology. Thyroid 16(1):47–53PubMedCrossRef Burgess JR, Tucker P (2006) Incidence trends for papillary thyroid carcinoma and their correlation with thyroid surgery and thyroid fine-needle aspirate cytology. Thyroid 16(1):47–53PubMedCrossRef
27.
go back to reference Leennhardt L, Bernier MO, Boin-Pineau MH et al (2004) Advances in diagnostic practices affect thyroid cancer incidence in France. Eur J Endocrinol 150(2):133–139CrossRef Leennhardt L, Bernier MO, Boin-Pineau MH et al (2004) Advances in diagnostic practices affect thyroid cancer incidence in France. Eur J Endocrinol 150(2):133–139CrossRef
28.
go back to reference Hall SF, Walker H, Siemens R, Schneeberg A (2009) Increasing detection and increasing incidence in thyroid cancer. World J Surg 33(12):2567–2571PubMedCrossRef Hall SF, Walker H, Siemens R, Schneeberg A (2009) Increasing detection and increasing incidence in thyroid cancer. World J Surg 33(12):2567–2571PubMedCrossRef
29.
go back to reference Li M, Eastman CJ, Waite KV et al (2006) Are Australian children iodine deficient? Results of the Australian National Iodine Nutrition Study. Med J Aust 184:165–169PubMed Li M, Eastman CJ, Waite KV et al (2006) Are Australian children iodine deficient? Results of the Australian National Iodine Nutrition Study. Med J Aust 184:165–169PubMed
30.
go back to reference Grodski S, Brown T, Sidhu S et al (2008) Increasing incidence of thyroid cancer is due to increased pathologic detection. Surgery 144(6):1038–1043PubMedCrossRef Grodski S, Brown T, Sidhu S et al (2008) Increasing incidence of thyroid cancer is due to increased pathologic detection. Surgery 144(6):1038–1043PubMedCrossRef
Metadata
Title
Pathways to the diagnosis of thyroid cancer in New South Wales: a population-based cross-sectional study
Authors
Clare Kahn
Leonardo Simonella
Mark Sywak
Steven Boyages
Owen Ung
Dianne O’Connell
Publication date
01-01-2012
Publisher
Springer Netherlands
Published in
Cancer Causes & Control / Issue 1/2012
Print ISSN: 0957-5243
Electronic ISSN: 1573-7225
DOI
https://doi.org/10.1007/s10552-011-9852-2

Other articles of this Issue 1/2012

Cancer Causes & Control 1/2012 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine